Article Details

AstraZeneca notes positive phase III analysis for heart failure drug - MarketScreener

Retrieved on: 2022-11-07 20:01:54

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca notes positive phase III analysis for heart failure drug - MarketScreener. View article details on hiswai:

Excerpt

(Alliance News) - AstraZeneca PLC on Monday shared more positive data for Farxiga for use in the treatment of heart failure.

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up